Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.84 HKD | +2.86% | +1.94% | -5.79% |
Apr. 26 | CSPC Pharmaceutical Group Limited Announces Highly Selective Mat2A Inhibitor Obtains Clinical Trial Approval in the U.S | CI |
Apr. 24 | CSPC Pharmaceutical's EBT Buys 8.5 Million Shares | MT |